Literature DB >> 29865067

Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment.

Igor Akushevich1, Arseniy P Yashkin1, Julia Kravchenko2, Svetlana Ukraintseva1, Eric Stallard1, Anatoliy I Yashin1.   

Abstract

BACKGROUND: Trends in the prevalence of cognitive impairment (CI) based on cognitive assessment instruments are often inconsistent with those of neurocognitive disorders (ND) based on Medicare claims records.
OBJECTIVE: We hypothesized that improved ascertainment and resulting decrease in disease severity at the time of diagnosis are responsible for this phenomenon.
METHODS: Using Medicare data linked to the Health and Retirement Study (1992-2012), we performed a joint analysis of trends in CI and ND to test our hypothesis.
RESULTS: We identified two major contributors to the divergent directions in CI and ND trends: reductions in disease severity explained more than 60% of the differences between CI and ND prevalence over the study period; the remaining 40% was explained by a decrease in the fraction of undiagnosed individuals. DISCUSSION: Improvements in the diagnoses of ND diseases were a major contributor to reported trends in ND and CI. Recent forecasts of CI and ND trends in the U.S. may be overly pessimistic.

Entities:  

Keywords:  Alzheimer’s disease; Ascertainment; Health and Retirement Study (HRS); Medicare; Telephone Interview for Cognitive Status (TICS); cognitive impairment; disease prevalence; neurocognitive disorders; severity; time trends; underdiagnosis

Mesh:

Year:  2018        PMID: 29865067      PMCID: PMC6214183          DOI: 10.3233/JAD-180060

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  44 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Clifford R Jack; Marilyn S Albert; David S Knopman; Guy M McKhann; Reisa A Sperling; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 3.  Mild cognitive impairment: disparity of incidence and prevalence estimates.

Authors:  Alex Ward; H Michael Arrighi; Shannon Michels; Jesse M Cedarbaum
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

Review 4.  Therapeutic strategies for Alzheimer's disease in clinical trials.

Authors:  Justyna Godyń; Jakub Jończyk; Dawid Panek; Barbara Malawska
Journal:  Pharmacol Rep       Date:  2015-08-05       Impact factor: 3.024

5.  Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

Authors:  Harm J van de Haar; Saartje Burgmans; Jacobus F A Jansen; Matthias J P van Osch; Mark A van Buchem; Majon Muller; Paul A M Hofman; Frans R J Verhey; Walter H Backes
Journal:  Radiology       Date:  2016-05-31       Impact factor: 11.105

6.  Identifying the causes of the changes in the prevalence patterns of diabetes in older U.S. adults: A new trend partitioning approach.

Authors:  Igor Akushevich; Arseniy P Yashkin; Julia Kravchenko; Fang Fang; Konstantin Arbeev; Frank Sloan; Anatoliy I Yashin
Journal:  J Diabetes Complications       Date:  2018-01-06       Impact factor: 2.852

7.  A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients.

Authors:  E Pfeiffer
Journal:  J Am Geriatr Soc       Date:  1975-10       Impact factor: 5.562

8.  Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study.

Authors:  E M C Schrijvers; B F J Verhaaren; P J Koudstaal; A Hofman; M A Ikram; M M B Breteler
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

9.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  A Lobo; L J Launer; L Fratiglioni; K Andersen; A Di Carlo; M M Breteler; J R Copeland; J F Dartigues; C Jagger; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

Review 10.  The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials.

Authors:  C Groot; A M Hooghiemstra; P G H M Raijmakers; B N M van Berckel; P Scheltens; E J A Scherder; W M van der Flier; R Ossenkoppele
Journal:  Ageing Res Rev       Date:  2015-11-28       Impact factor: 10.895

View more
  14 in total

1.  The Alzheimer's Disease Exposome.

Authors:  Caleb E Finch; Alexander M Kulminski
Journal:  Alzheimers Dement       Date:  2019-09-10       Impact factor: 21.566

2.  Attributable Cost of Dementia: Demonstrating Pitfalls of Ignoring Multiple Health Care System Utilization.

Authors:  Lianlian Lei; Susan G Cooley; Ciaran S Phibbs; Bruce Kinosian; Richard M Allman; Anton P Porsteinsson; Orna Intrator
Journal:  Health Serv Res       Date:  2018-09-23       Impact factor: 3.402

3.  Time trends in the prevalence of cancer and non-cancer diseases among older U.S. adults: Medicare-based analysis.

Authors:  Igor Akushevich; Julia Kravchenko; Arseniy P Yashkin; Anatoliy I Yashin
Journal:  Exp Gerontol       Date:  2018-06-19       Impact factor: 4.032

4.  Measuring Alzheimer's Disease and Other Dementias in Diverse Populations Using Medicare Claims Data.

Authors:  Johanna Thunell; Patricia Ferido; Julie Zissimopoulos
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  Chemotherapy and the Risk of Alzheimer's Disease in Colorectal Cancer Survivors: Evidence From the Medicare System.

Authors:  Igor Akushevich; Arseniy P Yashkin; Julia Kravchenko; Miklos D Kertai
Journal:  JCO Oncol Pract       Date:  2021-02-25

6.  Using Medicare claims in identifying Alzheimer's disease and related dementias.

Authors:  Siddharth Jain; Paul R Rosenbaum; Joseph G Reiter; Geoffrey Hoffman; Dylan S Small; Jinkyung Ha; Alexander S Hill; David A Wolk; Timothy Gaulton; Mark D Neuman; Roderic G Eckenhoff; Lee A Fleisher; Jeffrey H Silber
Journal:  Alzheimers Dement       Date:  2020-10-08       Impact factor: 21.566

7.  Geographic disparities in mortality from Alzheimer's disease and related dementias.

Authors:  Igor Akushevich; Arseniy P Yashkin; Anatoliy I Yashin; Julia Kravchenko
Journal:  J Am Geriatr Soc       Date:  2021-05-19       Impact factor: 7.538

8.  Analysis of Time Trends in Alzheimer's Disease and Related Dementias Using Partitioning Approach.

Authors:  Igor Akushevich; Arseniy P Yashkin; Julia Kravchenko; Anatoliy I Yashin
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

9.  Detection of Mild Cognitive Impairment and Alzheimer's Disease using Dual-task Gait Assessments and Machine Learning.

Authors:  Behnaz Ghoraani; Lillian N Boettcher; Murtadha D Hssayeni; Amie Rosenfeld; Magdalena I Tolea; James E Galvin
Journal:  Biomed Signal Process Control       Date:  2020-10-16       Impact factor: 3.880

10.  Dual-Task Gait Assessment and Machine Learning for Early-detection of Cognitive Decline.

Authors:  Lillian N Boettcher; Murtadha Hssayeni; Amie Rosenfeld; Magdalena I Tolea; James E Galvin; Behnaz Ghoraani
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.